Dáil Éireann Debate, Tuesday - 21 May 2019
408. Deputy Mary Lou McDonald asked the Minister for Health if the HSE Leadership Team met on 14 May 2019 to consider additional information submitted by the manufacturer of the drug Spinraza; and when the team will make a final decision on the reimbursement of the drug based on this information. [21754/19]
Amharc ar fhreagra452. Deputy Eoin Ó Broin asked the Minister for Health the outcome of the HSE Leadership Team meeting on 14 May 2019 with respect to the issue of Spinraza; and when the drug will be made available to those that need it. [22020/19]
Amharc ar fhreagraI propose to take Questions Nos. 408 and 452 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
